Toyia James-Stevenson

Toyia James-Stevenson

Auto-generated profile, based on publicly available information

Toyia James-Stevenson

Indiana University School of Medicine, Indianapolis, Indiana (D.K.R., I.B., M.F., A.G., T.J., S.K., T.N., I.O., N.R., S.S., A.S., R.S.)

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2022 in Clinical and Translational Gastroenterology
Verified
Journal Article
Open access
MWMohammed Rayyan Waseem
Mohammed Rayyan Waseem
ASAndrea Shin
Andrea Shin
RSRobert Siwiec
Robert Siwiec
TJToyia James-Stevenson
Toyia James-Stevenson
MBMatthew Bohm
Matthew Bohm
HXHuiping Xu
Huiping Xu
INTRODUCTION: Short-chain fatty acids (SCFAs) correlate with colonic transit time (CTT) and may influence irritable bowel syndrome (IBS) pathophysiology. However, the clinical significance of fecal SCFAs, relationships between SCFAs and other metabolites (bile acids [BAs]), and real-time diet effects on SCFAs in IBS are uncertain. The aim was to evaluate fecal SCFA associations with IBS phenotype and mechanisms and explore effects of real-time diet. METHODS: We conducted a prospective observational study of fecal SCFA, BAs, and CTT in healthy controls (HCs) and participants with IBS. We compared study end points across groups, analyzed relationships between end points, and evaluated the discriminative ability of SCFAs. Diet effects were explored in participants with dietary data. RESULTS: Among 21 HCs and 43 participants with IBS, fecal SCFAs (total, individual) were inversely correlated with overall (all P < 0.01) and segmental (all P < 0.05) CTT; similar associations were observed within HC and IBS groups. The acetate-to-butyrate ratio correlated with slower overall and left CTT in all and in HCs (both P < 0.01). SCFAs (total, acetate) correlated with BAs (total, % primary) in all participants and in those with IBS with diarrhea. Logistic regression analyses demonstrated associations of acetate with slower transit (odds ratio = 0.988, P = 0.002) and BA diarrhea (BAD; odds ratio = 1.014, P = 0.001). Acetate accurately predicted delayed CTT (area under the receiving operating characteristic curve = 0.84) and BAD (area under the receiver operating characteristic curve = 0.79). Adjusting for diet strengthened correlations of total SCFAs with overall CTT (R = [−0.46], P = 0.04) and SCFAs with transverse CTT (all P < 0.05). DISCUSSION: Fecal SCFAs correlate with CTT and fecal BAs and reliably exclude delayed CTT and BAD. Accounting for diet strengthens SCFA associations with transit.

1 July 2024 in Annals of Internal Medicine
Verified
Journal Article
Closed access
DRDouglas K. Rex
Douglas K. Rex
IBIndira Bhavsar-Burke
Indira Bhavsar-Burke
DBDaniel Buckles
Daniel Buckles
JBJames Burton
James Burton
ACAmanda Cartee
Amanda Cartee
ARAmit Rastogi
Amit Rastogi
Real-time prediction of histologic features of small colorectal polyps may prevent resection and/or pathologic evaluation and therefore decrease colonoscopy costs. Previous studies showed that computer-aided diagnosis (CADx) was highly accurate, though it did not outperform expert endoscopists. To assess the diagnostic performance of histologic predictions by general endoscopists before and after assistance from CADx in a real-life setting. Prospective, multicenter, single-group study. (ClinicalTrials.gov: NCT04437615). 6 centers across the United States. 1252 consecutive patients undergoing colonoscopy and 49 general endoscopists with variable experience in real-time prediction of polyp histologic features. Real-time use of CADx during routine colonoscopy. The primary end points were the sensitivity and specificity of CADx-unassisted and CADx-assisted histologic predictions for adenomas measuring 5 mm or less. For clinical purposes, additional estimates according to location and confidence level were provided. The CADx device made a diagnosis for 2695 polyps measuring 5 mm or less (96%) in 1252 patients. There was no difference in sensitivity between the unassisted and assisted groups (90.7% vs. 90.8%; P = 0.52). Specificity was higher in the CADx-assisted group (59.5% vs. 64.7%; P < 0.001). Among all 2695 polyps measuring 5 mm or less, 88.2% and 86.1% (P < 0.001) in the CADx-assisted and unassisted groups, respectively, could be resected and discarded without pathologic evaluation. Among 743 rectosigmoid polyps measuring 5 mm or less, 49.5% and 47.9% (P < 0.001) in the CADx-assisted and unassisted groups, respectively, could be left in situ without resection. Decision making based on CADx might differ outside a clinical trial. CADx assistance did not result in increased sensitivity of optical diagnosis. Despite a slight increase, the specificity of CADx-assisted diagnosis remained suboptimal. Olympus America Corporation served as the clinical study sponsor.

7 March 2017 in American Journal of Case Reports
Verified
Journal Article
Open access
PDF file
GSGouri Sreepati
Gouri Sreepati
TJToyia James-Stevenson
Toyia James-Stevenson
Rare co-existance of disease or pathology Fecal incontinence and constipation are common gastrointestinal complaints, but rarely occur concurrently. Management of these seemingly paradoxical processes is challenging, as treatment of one symptom may exacerbate the other. A 51-year-old female with lifelong neurogenic bladder secondary to spina bifida occulta presented with progressive symptoms of daily urge fecal incontinence as well as hard bowel movements associated with straining and a sensation of incomplete evacuation requiring manual disimpaction. Pelvic floor testing showed poor ability to squeeze the anal sphincter, which indicated sphincter weakness as a major contributor to her fecal incontinence symptoms. Additionally, on defecography she was unable to widen her posterior anorectal angle or relax the anal sphincter during defecation consistent with dyssynergic defecation. A sacral nerve stimulator was placed for management of her fecal incontinence. Interestingly, her constipation also dramatically improved with sacral neuromodulation. This unique case highlights the emerging role of sacral nerve stimulation in the treatment of complex pelvic floor dysfunction with improvement in symptoms beyond fecal incontinence in a patient with dyssynergic-type constipation.

1 November 2020 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
TJToyia James-Stevenson
Toyia James-Stevenson

16 June 2022 in Gastroenterology
Verified
Journal Article
Closed access
ASAndrea Shin
Andrea Shin
AMAnne Mary Montero
Anne Mary Montero
SJSean Jones
Sean Jones
TJToyia N. James-Stevenson
Toyia N. James-Stevenson
JKJhalka Kadariya
Jhalka Kadariya
HXHuiping Xu
Huiping Xu

7 June 2022 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
MDMadhav Desai
Madhav Desai
DRDouglas K. Rex
Douglas K. Rex
MBMatthew Bohm
Matthew Bohm
PDPerica Davitkov
Perica Davitkov
JDJohn M. Dewitt
John M. Dewitt
PSPrateek Sharma
Prateek Sharma